A detailed history of Groupama Asset Managment transactions in Eli Lilly & CO stock. As of the latest transaction made, Groupama Asset Managment holds 88,465 shares of LLY stock, worth $67.9 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares
88,465
Previous 88,007 0.52%
Holding current value
$67.9 Million
Previous $79.7 Billion 21.03%
% of portfolio
1.63%
Previous 1.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $353,640 - $439,689
458 Added 0.52%
88,465 $62.9 Billion
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $5.06 Million - $6.34 Million
6,975 Added 8.61%
88,007 $79.7 Billion
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $9.7 Million - $13 Million
-16,372 Reduced 16.81%
81,032 $71.8 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $51.2 Million - $60.3 Million
97,404 New
97,404 $56.8 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.